Join
Live feed
·
PRReleasevia Quantisnow
Flexible Solutions International Inc. logo

FSI ANNOUNCES CAPEX EXPENDITURE TO ACQUIRE A VIAL FILLING LINE FOR INJECTABLE DRUGS SUCH AS GLP1 FOR WEIGHT LOSS

ByQuantisnow·Wall Street's wire, on your screen.
FSI· Flexible Solutions International Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FSI (Flexible Solutions International Inc.) and more on Quantisnow.